- Home
- Companies
- canada nova scotia
- antibiotic resistant
Refine by
Antibiotic Resistant Technology Serving Nova Scotia
6 companies found
Technologybased inSALUGGIA, ITALY
We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the ...
The VERIGENE System enables clinicians to rapidly identify the pathogens responsible for some of the most complex, costly, and deadly infectious ...
Technologybased inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
Antimicrobial resistance (AMR) can arise when the organisms that cause an infection evolve ways to survive and render treatments ineffective, facilitating the infection’s spread. Global human consumption of ...
Technologybased inSeraing, BELGIUM
Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins to improve microbial fermentation. Our team of scientists works in different academic laboratories and our R&D programs involve partners from ...
Syngulon develops antibiotic-free technologies for use in so-called “micro-refineries”, microbial cells that have been engineered to produce industrially relevant compounds. These technologies incorporate bacteriocins into the ...
Technologybased inTurku, FINLAND
Bonalive is a smart biomaterials company transforming the future of healthcare. With one of the most evidence-based technologies in the industry, we are creating a smarter future for healthcare. We exist to restore and sustain human life. Our ...
Technologybased inVancouver, BRITISH COLUMBIA (CANADA)
Ondine Biomedical Inc. is a Canadian life sciences company that has become a global leader in photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. This patented ...
Reduce incidence of transmission and infections with photodisinfection. The nose is a primary home of bacteria, viruses, and fungi, which can be transmitted before any symptoms occur, adding risk to employees and their families. 1-4, 9. Handwashing, ...
Technologybased inNorwich, UNITED KINGDOM
We are a passionate and skilled drug discovery and development biotech team developing an innovative new class of oligonucleotide antimicrobial agents. Procarta is currently working on lead optimisation for its first product, a narrow-spectrum agent ...
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required ...
